Cannara Biotech Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Public

  • Employees
  • 363

Employees

  • Stock Symbol
  • LOVE

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $1.40
  • (As of Friday Closing)

Cannara Biotech General Information

Description

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .

Contact Information

Website
www.cannara.ca
Formerly Known As
Dunbar Capital
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 333 Decarie Boulevard
  • Suite 200
  • Saint Laurent, Quebec H4N 3M9
  • Canada
+1 (514)
Primary Industry
Cultivation
Other Industries
Pharmaceuticals
Other Consumer Non-Durables
Stock Exchange
TSE
Vertical(s)
Corporate Office
  • 333 Decarie Boulevard
  • Suite 200
  • Saint Laurent, Quebec H4N 3M9
  • Canada
+1 (514)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cannara Biotech Stock Performance

As of 20-Nov-2026, Cannara Biotech’s stock price is $1.40. Its current market cap is $138M with 98.8M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.40 $1.41 $1.09 - $1.68 $138M 98.8M 38.7K $0.08

Cannara Biotech Financials Summary

As of 31-May-2026, Cannara Biotech has a trailing 12-month revenue of $85.1M.

In Thousands,
USD
TTM 31-May-2026 FY 2025 31-Aug-2025 FY 2024 31-Aug-2024 FY 2023 31-Aug-2023
EV 128,619 143,725 77,558 96,715
Revenue 85,068 76,666 60,071 42,478
EBITDA 18,125 20,214 11,393 12,002
Net Income 7,872 9,351 4,731 5,152
Total Assets 140,871 122,616 114,650 104,546
Total Debt 26,799 30,232 35,811 33,821
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cannara Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cannara Biotech‘s full profile, request access.

Request a free trial

Cannara Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cannara Biotech Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cannara Biotech‘s full profile, request access.

Request a free trial

Cannara Biotech Investments & Acquisitions (3)

Cannara Biotech’s most recent deal was a Merger/Acquisition with Medican Organic for . The deal was made on 05-May-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Medican Organic 05-May-2026 Merger/Acquisition Cultivation
Medican Organic (Cultivation and Manufacturing Facility in Valleyfield, Quebec) 23-Jun-2021 Corporate Asset Purchase Buildings and Property
Global shopCBD.com 06-Jul-2020 Merger/Acquisition Specialty Retail
To view Cannara Biotech’s complete investments and acquisitions history, request access »

Cannara Biotech ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Food Products

Industry

Rank

Percentile

Agriculture

Subindustry

Rank

Percentile

To view Cannara Biotech’s complete esg history, request access »

Cannara Biotech Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Cannara Biotech (ops) Saint-Laurent, Canada 2018

Cannara Biotech FAQs

  • When was Cannara Biotech founded?

    Cannara Biotech was founded in 2017.

  • Where is Cannara Biotech headquartered?

    Cannara Biotech is headquartered in Saint Laurent, Canada.

  • What is the size of Cannara Biotech?

    Cannara Biotech has 363 total employees.

  • What industry is Cannara Biotech in?

    Cannara Biotech’s primary industry is Cultivation.

  • Is Cannara Biotech a private or public company?

    Cannara Biotech is a Public company.

  • What is Cannara Biotech’s stock symbol?

    The ticker symbol for Cannara Biotech is LOVE.

  • What is the current stock price of Cannara Biotech?

    As of 20-Nov-2026 the stock price of Cannara Biotech is $1.40.

  • What is the current market cap of Cannara Biotech?

    The current market capitalization of Cannara Biotech is $138M.

  • What is Cannara Biotech’s current revenue?

    The trailing twelve month revenue for Cannara Biotech is $85.1M.

  • What is Cannara Biotech’s annual earnings per share (EPS)?

    Cannara Biotech’s EPS for 12 months was $0.08.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process